Original Articles
Vol. 6 (2011)
INTRA-ARTICULAR INJECTION OF HYALURONIC ACID IN PATIENTS AFFECTED BY CROHN-LESNIOWSKI DISEASE
Publisher's note
All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.
All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.
Published: January 12 2026
91
Views
42
Downloads
Authors
The pain and functional limitations caused by osteoarthritis in joints have multiple eti- ologies and often involve inflammatory mechanisms. The first level of medical interven- tion consists of therapeutic use of NSAIDs or steroids when no complications are pre- sent. Such therapies could be ineffective, or cause drug-related complications, prompt- ing the suspension of treatment. In these cases, intra-articular injections of high molecular weight hyaluronic acid can be administered in order to reach therapeutic goals. Patients with Crohn-Lesniowski disease, affected by osteoarthritis of the shoulder or the knee, were included in this study.
Downloads
Download data is not yet available.
Citations
How to Cite
INTRA-ARTICULAR INJECTION OF HYALURONIC ACID IN PATIENTS AFFECTED BY CROHN-LESNIOWSKI DISEASE. (2026). EuroMediterranean Biomedical Journal, 6. https://doi.org/10.3269/1970-5492.2011.6.16
Copyright (c) 2026 The Author(s)
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.